Patent Application
App. No. 15/370,588
UNITARY PHARMACEUTICAL DOSAGE FORM
Loading inventors, assignments & file history…
Abstract
In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation.
Claims (2)
1 . A composition comprising tenofovir DF and a surfactant whereby the surfactant is in a stabilizing configuration with the tenofovir DF.
2 - 30 . (canceled)
Assignments (4)
CHANGE OF NAME
Recorded Feb 7, 2018
From: BRISTOL-MYERS SQUIBB & GILEAD SCIENCES, LLC
To: GILEAD SCIENCES, LLC
Reel/Frame 045269/0982 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 9, 2017
From: DAHL, TERRENCE C.; HUSSAIN, MUNIR A.; LIPPER, ROBERT A.; JERZEWSKI, ROBERT L.; MENNING, MARK M.; OLIYAI, REZA; YANG, TAIYIN
To: BRISTOL-MYERS SQUIBB & GILEAD SCIENCES, LLC
Reel/Frame 044085/0005 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEES NAME PREVIOUSLY RECORDED ON REEL 041890 FRAME 0080. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Recorded Jun 28, 2017
From: DAHL, TERRENCE C.; HUSSAIN, MUNIR A.; LIPPER, ROBERT A.; JERZEWSKI, ROBERT L.; MENNING, MARK M.; OLIYAI, REZA; YANG, TAIYIN
To: BRISTOL-MYERS SQUIBB & GILEAD SCIENCES, INC.
Reel/Frame 043028/0490 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 6, 2017
From: DAHL, TERRENCE C.; HUSSAIN, MUNIR A.; LIPPER, ROBERT A.; JERZEWSKI, ROBERT L.; MENNING, MARK M.; OLIYAI, REZA; YANG, TAIYIN
To: GILEAD SCIENCES, INC.
Reel/Frame 041890/0080 →